Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals | Small Cap
Health Score : 7.43Chemcon Speciality Chemicals Ltd exhibits a mixed financial profile, characterized by exceptional strengths in some areas and notable weaknesses in others. The company's greatest strength is its outstanding financial stability, as it operates completely free of debt, which eliminates financial risk and provides maximum flexibility. Its profitability is also a highlight, with strong margins and returns on investment, indicating an efficient cost structure. However, there are significant concerns regarding its operational efficiency. The company is slow to sell its inventory and collect payments, and it does not use its assets effectively to generate sales. Furthermore, while long-term growth metrics appear favorable, recent performance shows a sharp decline in revenue and profits, pointing to current market or operational challenges. The company's high liquidity provides a solid cushion to navigate these issues, but its future performance depends on addressing its operational inefficiencies and reversing the recent negative growth trend.
Health Score : 7.43Chemcon Speciality Chemicals Ltd exhibits a mixed financial profile, characterized by exceptional strengths in some areas and notable weaknesses in others. The company's greatest strength is its outstanding financial stability, as it operates completely free of debt, which eliminates financial risk and provides maximum flexibility. Its profitability is also a highlight, with strong margins and returns on investment, indicating an efficient cost structure. However, there are significant concerns regarding its operational efficiency. The company is slow to sell its inventory and collect payments, and it does not use its assets effectively to generate sales. Furthermore, while long-term growth metrics appear favorable, recent performance shows a sharp decline in revenue and profits, pointing to current market or operational challenges. The company's high liquidity provides a solid cushion to navigate these issues, but its future performance depends on addressing its operational inefficiencies and reversing the recent negative growth trend.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
31.54
Industry Median
31.54
Small Cap Median
29.58
P/E RATIO
31.54
P/B RATIO
1.54
Industry Median
2.55
Small Cap Median
2.31
P/S RATIO
3.16
Industry Median
2.29
Small Cap Median
1.93
Others
PEG RATIO
0.00
EV/EBITDA RATIO
13.41
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹203.14 as on Sep 28, 2026.
Growth Score : 4.80The company's growth profile presents a concerning and contradictory picture. The weighted average calculation, which includes historical data and future projections, results in a moderate score. However, this masks a sharp and significant recent decline in both profits and earnings. While asset growth remains positive, it is not translating into profit growth. This indicates that while past performance may have been strong, the company is currently facing significant headwinds that are eroding its profitability.
Revenue Growth RateExcellentOperating Profit Growth RatePoorEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 5.76 | 17.9 | -11.88 | -22.47 | 15.94 |
| Operating Profit Growth Rate | 1.23 | -13.41 | -61.97 | 22.22 | -9.09 |
| Earnings Per Share (EPS) Growth | 11.23 | -12.2 | -65.16 | 27.29 | -3.45 |
| Asset Growth Rate | 23.27 | 11.04 | -1.45 | 1.65 | |
| Net Income Growth Rate | 12.5 | -12.7 | -65.45 | 26.32 | 0 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Plastiblends India Ltd | 8.55 | 13.14 | Highly Undervalued | 53.00 | 14.12 | 37.00 |
| 2 | Excel Industries Ltd | 8.39 | 16.87 | Neutral | 110.00 | 58.39 | 76.00 |
| 3 | Chemcon Speciality Chemicals Ltd | 7.43 | 31.54 | Neutral | 38.00 | 7.69 | 28.00 |
| 4 | Aarti Surfactants Ltd | 7.41 | 44.30 | Undervalued | 47.00 | 14.97 | 12.00 |
| 5 | Dynemic Products Ltd | 6.97 | 14.35 | Neutral | 52.00 | 16.33 | 20.00 |
| 6 | Kronox Lab Sciences Ltd | 6.01 | 24.99 | Neutral | 34.00 | 7.45 | 28.00 |
| 7 | Oriental Aromatics Ltd | 5.65 | 455.41 | Neutral | 68.00 | 7.51 | 3.00 |
| 8 | HP Adhesives Ltd | 5.19 | 45.96 | Neutral | 13.00 | 0.75 | 7.00 |
| 9 | Godavari Biorefineries Ltd | 4.15 | 340.51 | Neutral | 127.00 | 0.24 | 4.00 |
| 10 | DIC India Ltd | 3.63 | 23.03 | Undervalued | 42.00 | 20.73 | 22.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
No Stock News Available at This Moment.
Chemcon Speciality Chemicals Ltd. is a leading manufacturer of specialty chemicals in India, primarily focusing on Pharma Intermediates and Oilfield Chemicals. It holds a significant global market share in products like HMDS and CMIC, serving critical raw material needs for pharmaceutical, agrochemical, and oil & gas industries.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Chemcon Speciality Chemicals Ltd's P/E ratio (TTM) is 31.54, compared to the industry median of 31.54 and large cap median of 29.58.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Chemcon Speciality Chemicals Ltd's P/B ratio is 1.54, compared to the industry median of 2.55 and large cap median of 2.31.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Chemcon Speciality Chemicals Ltd's P/S ratio is 3.16, compared to the industry median of 2.29 and large cap median of 1.93.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Chemcon Speciality Chemicals Ltd's PEG ratio is 1.05.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Chemcon Speciality Chemicals Ltd's EV/EBITDA ratio is 13.41.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Chemcon Speciality Chemicals Ltd's ROE is 4.79%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Chemcon Speciality Chemicals Ltd's ROA is 5.96%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Chemcon Speciality Chemicals Ltd's ROCE is 6%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Chemcon Speciality Chemicals Ltd's operating margin is 12.50%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Chemcon Speciality Chemicals Ltd's net margin is 10%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Chemcon Speciality Chemicals Ltd's current ratio is 6.70.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Chemcon Speciality Chemicals Ltd's debt-to-equity ratio is 0.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Chemcon Speciality Chemicals Ltd's interest coverage ratio is 17.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Chemcon Speciality Chemicals Ltd's DPS is ₹6.50.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Chemcon Speciality Chemicals Ltd's EPS is -3.45.
(Source line: "Ratios as of 08 Oct 2026, based on last traded price of ₹203.14. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1988
Headquarters: Vadodara, Gujarat
Core Offerings: Hexamethyldisilazane (HMDS), Chloromethyl Isopropyl Carbonate (CMIC), Bromine derivatives, Oilfield chemicals
Stock Listing: NSE (CHEMCON), BSE (543233)
Promoter: Kamalkumar Rajendra Aggarwal and Naresh Vijaykumar Goyal
1988: Incorporated as Chemcon Speciality Chemicals Private Limited in Vadodara, Gujarat. 1990: Commenced commercial operations with the manufacturing of Hexamethyldisilazane (HMDS). 2000s: Expanded product portfolio to include Chloromethyl Isopropyl Carbonate (CMIC) and various oilfield chemicals. 2020: Converted to a public limited company and successfully completed an Initial Public Offering (IPO) on NSE and BSE. Present: Continues to be a key global supplier of specialty chemicals, known for its focus on quality and R&D.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Pharma Intermediates | ~74.6% | Operating Profit |
| Oilfield Chemicals | ~25.4% | Operating Profit |
Pharma Intermediates: Manufactures key pharmaceutical intermediates like Hexamethyldisilazane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC), crucial for producing antiretroviral, anti-diabetic, and anti-fungal drugs, and also used as silylation agents.
Oilfield Chemicals: Produces high-performance Completion Fluids for the oil & gas industry, primarily utilized in exploration and production activities to enhance well productivity and reservoir integrity.
Mr. Naresh Vijaykumar Goyal - Whole-time Director & CEO. He is a co-promoter and instrumental in business development and operational management. Mr. Kamalkumar Rajendra Aggarwal - Whole-time Director & CFO. As a co-promoter, he brings extensive experience in the chemical industry and oversees financial operations.
No major subsidiaries reported.
No major recent corporate actions on record.
The Chemcon Speciality Chemicals Ltd share price today is ₹203.14 on NSE (CHEMCON), as of 08 Oct 2026.
As of 08 Oct 2026, Chemcon Speciality Chemicals Ltd share price is ₹203.14, with previous close ₹203.14. Today's range is ₹203.14 to ₹203.14. The 52-week range is ₹N/A to ₹N/A.
As of today, Chemcon Speciality Chemicals Ltd's market cap is ₹757.71 crore (Small Cap).
Chemcon Speciality Chemicals Ltd's current P/E ratio is 31.54, compared to the CHEMICALS & PETROCHEMICALS sector average of 26.80.
Chemcon Speciality Chemicals Ltd's current P/B ratio is 1.54.
Chemcon Speciality Chemicals Ltd's current dividend yield is 3.20%. Last dividend of ₹2.50 per share was declared on 21-Aug-2023.
Chemcon Speciality Chemicals Ltd's EPS (TTM) is ₹-3.45.
Chemcon Speciality Chemicals Ltd. is a leading manufacturer of specialty chemicals in India, primarily focusing on Pharma Intermediates and Oilfield Chemicals. It holds a significant global market share in products like HMDS and CMIC, serving critical raw material needs for pharmaceutical, agrochemical, and oil & gas industries.
Chemcon Speciality Chemicals Ltd is promoted by Kamalkumar Rajendra Aggarwal and Naresh Vijaykumar Goyal, holding 74.47% as of 08 Oct 2026.
Chemcon Speciality Chemicals Ltd is listed on NSE (CHEMCON) and BSE (543233). Its next quarterly results are expected on July/August 2024 (Q1 FY25).